CID 16072303

N-[[(1s)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-tetrahydroxy-[(1r)-1-hydroxyethyl]-(hydroxymethyl)-methyl-heptaoxo-[?]yl]-12-methyl-tetradecanamide

Structural Information

Molecular Formula
C49H78N8O17
SMILES
CCC(C)CCCCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)C2[C@H]([C@H](CN2C(=O)C(NC(=O)C(NC(=O)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H](C(C4=CC=C(C=C4)O)O)O)CO)C)O)O)O
InChI
InChI=1S/C49H78N8O17/c1-5-25(2)14-12-10-8-6-7-9-11-13-15-35(63)50-31-21-34(62)44(69)54-46(71)38-39(64)26(3)22-57(38)47(72)32(24-58)51-45(70)37(41(66)40(65)28-16-18-29(60)19-17-28)53-49(74)55-43(68)33-20-30(61)23-56(33)48(73)36(27(4)59)52-42(31)67/h16-19,25-27,30-34,36-41,44,58-62,64-66,69H,5-15,20-24H2,1-4H3,(H,50,63)(H,51,70)(H,52,67)(H,54,71)(H2,53,55,68,74)/t25?,26-,27+,30+,31-,32?,33-,34+,36-,37?,38?,39-,40?,41-,44+/m0/s1
InChIKey
UXIRFQPBPZYIBV-QQTLFGACSA-N
Compound name
N-[(11S,13R,17S,20S,22R,23R,27S,28S)-6-[(1S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-13,22,23,27-tetrahydroxy-17-[(1R)-1-hydroxyethyl]-3-(hydroxymethyl)-28-methyl-2,5,8,10,16,19,25-heptaoxo-1,4,7,9,15,18,24-heptazatricyclo[24.3.0.011,15]nonacosan-20-yl]-12-methyltetradecanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

3
References

0
Patents

1050.5485 Da
Monoisotopic Mass

1.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 1051.5558 301.4
[M+Na]+ 1073.5377 300.9
[M-H]- 1049.5412 291.4
[M+NH4]+ 1068.5823 297.1
[M+K]+ 1089.5117 287.7
[M+H-H2O]+ 1033.5458 271.5
[M+HCOO]- 1095.5467 297.2
[M+CH3COO]- 1109.5624 299.4
[M+Na-2H]- 1071.5232 301.3
[M]+ 1050.5480 300.4
[M]- 1050.5490 300.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.